Untreated masked hypertension and carotid atherosclerosis: a meta-analysis

Cesare Cuspidi1, Carla Sala, Marijana Tadic

  • 1Department of Health Science, University of Milano-Bicocca , Milan , Italy.

Blood Pressure
|January 23, 2015
PubMed

Insights

Masked hypertension (MH) is linked to increased carotid atherosclerosis risk. Early detection through carotid ultrasound may improve cardiovascular risk assessment in these patients.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Hypertension Research

Background:

  • Masked hypertension (MH) is a recognized clinical condition associated with poor cardiovascular outcomes.
  • Limited research has explored the impact of MH on subclinical vascular damage, particularly carotid atherosclerosis.
  • This meta-analysis focuses on evaluating the link between MH and early signs of carotid artery disease in untreated individuals.

Purpose of the Study:

  • To conduct a meta-analysis assessing the association between masked hypertension and subclinical carotid atherosclerosis.
  • To investigate whether MH is linked to increased carotid intima-media thickness (IMT) in untreated adults.
  • To determine the implications of MH for cardiovascular risk stratification.

Main Methods:

  • A systematic literature search was performed using keywords related to masked hypertension, carotid atherosclerosis, and intima-media thickness.
  • Included studies focused on untreated adult individuals and reported data on carotid IMT.
  • Five studies involving 2752 participants (normotensive, MH, and hypertensive) were included in the meta-analysis.

Main Results:

  • Common carotid intima-media thickness (IMT) progressively increased from normotensive to masked hypertensive and sustained hypertensive subjects.
  • A significant association was found between MH and increased carotid IMT compared to normotensive individuals (SMD: 0.51 ± 0.19, p < 0.01).
  • The difference between MH and normotension became borderline after adjusting for publication bias, with sensitivity analysis confirming robustness.

Conclusions:

  • Masked hypertension is associated with a higher risk of developing early carotid atherosclerosis compared to true normotension.
  • Ultrasound assessment of preclinical carotid disease in MH patients can enhance cardiovascular risk stratification.
  • These findings suggest improved clinical decision-making strategies for individuals with masked hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
798
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
946
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K